Alvotech Net Receivables from 2010 to 2024

ALVO Stock  USD 11.68  0.16  1.35%   
Alvotech Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to drop to about 69.1 M. During the period from 2010 to 2024, Alvotech Net Receivables quarterly data regression pattern had sample variance of 247.8 T and median of  38,904,000. View All Fundamentals
 
Net Receivables  
First Reported
2010-12-31
Previous Quarter
87.2 M
Current Value
69.1 M
Quarterly Volatility
15.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Alvotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alvotech's main balance sheet or income statement drivers, such as Interest Income of 5.1 M, Depreciation And Amortization of 20.4 M or Interest Expense of 139.4 M, as well as many indicators such as Price To Sales Ratio of 33.56, Dividend Yield of 0.0 or Days Sales Outstanding of 282. Alvotech financial statements analysis is a perfect complement when working with Alvotech Valuation or Volatility modules.
  
Check out the analysis of Alvotech Correlation against competitors.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.

Latest Alvotech's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Alvotech over the last few years. It is Alvotech's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alvotech's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Alvotech Net Receivables Regression Statistics

Arithmetic Mean47,304,150
Geometric Mean45,396,123
Coefficient Of Variation33.28
Mean Deviation12,320,220
Median38,904,000
Standard Deviation15,741,077
Sample Variance247.8T
Range48.3M
R-Value0.73
Mean Square Error122.9T
R-Squared0.54
Significance0
Slope2,585,010
Total Sum of Squares3468.9T

Alvotech Net Receivables History

202469.1 M
202387.2 M
202271.4 M
202153.9 M

About Alvotech Financial Statements

Alvotech investors utilize fundamental indicators, such as Net Receivables, to predict how Alvotech Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables87.2 M69.1 M

Pair Trading with Alvotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alvotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will appreciate offsetting losses from the drop in the long position's value.

Moving together with Alvotech Stock

  0.8EWTX Edgewise TherapeuticsPairCorr
  0.65BHC Bausch Health CompaniesPairCorr

Moving against Alvotech Stock

  0.64MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.6ELAN Elanco Animal Health Potential GrowthPairCorr
  0.57HLN Haleon plcPairCorr
  0.52TAK Takeda PharmaceuticalPairCorr
  0.44JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
The ability to find closely correlated positions to Alvotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alvotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alvotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alvotech to buy it.
The correlation of Alvotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alvotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alvotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alvotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock:
Check out the analysis of Alvotech Correlation against competitors.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.70)
Earnings Share
(1.85)
Revenue Per Share
1.283
Quarterly Revenue Growth
43.997
Return On Assets
(0.08)
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.